Consensus document on the figure of the TAVI nurse in the haemodynamic working group of the Spanish Association of Nursing in Cardiology
Barra lateral del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
Contenido principal del artículo
Resumen
The TAVI Nurse is an advanced nursing practice figure that manages the process of patients undergoing transcatheter aortic valve implantation, from diagnosis to subsequent home care after the intervention. This figure is in charge of triage and coordination, clinical, functional, and psychosocial assessment, education of the patient and their family, and leadership of the TAVI program.
At the national level, there are no standardised competencies for the TAVI Nurse, therefore, it is necessary to elaborate a consensus document that defines their functions and competencies.
Via the creation of a group of TAVI procedure nursing experts, a methodology was designed for drafting this document by comparing scientific evidence and experiences in our setting, in order to reach a consensus on functions and competencies at the national level.
After drawing up this consensus document, the challenge in the coming years is to implement this figure in a large part of our country’s centres, with a quality register that can be evaluated with indicators that demonstrate the effectiveness of this figure.
Detalles del artículo
Referencias
D’Arcy JL, Prendergast BD, Chambers JB, Ray SG, Bridgewater B. Valvular heart disease: The next cardiac epidemic.
Heart. 2011;97(2):91–3.
Amonn K, Stortecky S, Brinks H, Gahl B, Windecker S, Wenaweser P, et al. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement.
Eur J Cardiothorac Surg. 2013;43(1):34–41
Lauck SB, McGladrey J, Lawlor C, Webb JG. Nursing leadership of the transcatheter aortic valve implantation Heart Team: Supporting innovation, excellence, and sustainability.
Healthc Manag forum. 2016;29(3):126–30.
Lauck SB, Baumbusch J, Achtem L, Forman JM, Carroll SL, Cheung A, et al. Factors influencing the decision of older adults to be assessed for transcatheter aortic valve implantation: An exploratory study.
Eur J Cardiovasc Nurs. 2016;15(7):486–94.
Hartley A, Hammond-Haley M, Marshall DC, et al. Trends in mortality fron aortic stenosis in Europe: 2000-2017.
Front Cardiovasc Med. 2021;8:748137.
Dworakowski R, MacCarthy PA, Monaghan M, Redwood S, El-Gamel A, Young C, et al. Transcatheter aortic valve implantation for severe aortic stenosis-A new paradigm for multidis-ciplinary intervention: a prospective cohort study.
Am Heart J. 2010;160(2):237–43.
Lauck SB, Wood DA, Baumbusch J, Kwon J-Y, Stub D, Achtem L, et al. Vancouver transcatheter aortic valve replacement clinical pathway: Minimalist approach, standardized care, and discharge criteria to reduce length of stay.
Circ Cardiovasc Qual Outcomes. 2016;9(3):312–21.
Lauck S, Achtem L, Boone RH, Cheung A, Lawlor C, Ye J, et al. Implementation of processes of care to support transcatheter aortic valve replacement programs.
Eur J Cardiovasc Nurs. 2013;12(1):33–8.
Thonghong T, De Backer O, Søndergaard L. Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease.
Open Heart. 2018;5(1):e000753.
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.
N Engl J Med. 2017;376(14):1321–31.
Lauck SB, Sathananthan J, Park J, Achtem L, Smith A, Keegan P, et al. Post-procedure protocol to facilitate next-day discharge. Results of the multidisciplinary, multimodality but minimalist TAVR study.
Catheter Cardiovasc Interv.2020;96(2):450-8.
Hawkey MC, Lauck SB, Perpetua EM, Fowler J, Schnell S, Speight M, et al. Transcatheter aortic valve replacement program development: Recommendations for best practice.
Catheter Cardiovasc Interv. 2014;84(6):859–67.
Gialama F, Prezerakos P, Apostolopoulos V, Maniadakis N. Systematic review of the cost-effectiveness of transcatheter intervention for valvular heart disease. European Heart Journal.
Quality of Care & Clinical Outcomes. 2018;4(2):81-90.
Registro Nacional de Actividad en Cardiología Intervencionista 2021 [Internet] Asociación de Cardiología Intervencionista (Sociedad Española de Cardiología). 2021. [citado 15 de septiembre 2022].
Recuperado a partir de: https://www.hemodinamica.com/cientifico/registro-de-actividad/
Vivas D, Roldán I, Ferrandis R, Marín F, Roldán V, Tello-Montoliu A, et al. Manejo perioperatorio y periprocedimiento del tratamiento antitrombótico: documento de consenso de SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT y AEU.
Rev Española Cardiol [Internet]. 2018;71(7):553–64.
Alec Vahanian, Friedhelm Beyersdorf, Fabien Praz, Milan Milojevic, Stephan Baldus, Johann Bauersachs, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
Eur Heart J.2022;43(7):561-632.
Ramos GEL, Llibre-Rodríguez JJ. Fragilidad en el adulto mayor: Un primer acercamiento.
Revista Cubana de Medicina General Integral. 2004. 20(4)
Van Mourik MS, Velu JF, Lanting VR, Limpens J, Bouma BJ, Piek JJ, et al. Preoperative frailty parameters as predictors for outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
Neth Heart J.2020;28(5):280-92.
Díez-Villanueva P, Arizá-Solé A, Vidán MT, Bonanad C, Formiga F, Sanchis J, et al. Recomendaciones de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología para la valoración de la fragilidad en el anciano con cardiopatía.
Rev Esp Cardiol.2019;72(1):63-71.
Afilalo J, Lauck S, Kim DH, Lefèvre T, Piazza N, Lachapelle K, et al. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.
J Am Coll Cardiol. 8 de agosto de 2017;70(6):689-700.
Piankova P, Afilalo J. Prevalence and Prognostic Implications of Frailty in Transcatheter Aortic Valve Replacement.
Cardiol Clin. febrero de 2020;38(1):75-87.
Puls M, Sobisiak B, Jacobshagen C, Danner B, Schoendube F, Hasenfuss G, et al. Katz-Index effectively predicts long-term mortality after Transcatheter Aortic Valve Implantation (TAVI).
Eur Heart J [Internet]. 1 de agosto de 2013 [citado 18 de noviembre de 2021];34(suppl_1).
Byczkowska K, Pawlak A, Gil RJ. Katz frailty syndrom has no predictive value in low-risk patients undergoing transcatheter aortic valve implantation.
Eur Heart J [Internet]. 1 de octubre de 2021 [citado 18 de noviembre de 2021];42(Supplement_1).
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.
J Gerontol. 1994;49:M85-M94
Cid-Ruzafa J, Damián-Moreno J. Valoración de la discapacidad física: el índice de Barthel.
Rev. Esp. Salud Pública. 1997. 71(2)
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living.
Gerontologist. 1969;9:179-86
Martínez de la Iglesia J, Dueñas-Herrero R, Onís-Vilchesa MC, Aguado-Tabernea C, Albert-Colomerc C, Luque-Luque R. Adaptación y validación del cuestionario de Pfeiffer (SPMSQ) para detectar la existencia de deterioro cognitivo en personas mayores de 65 años. 2001.
Medicina Clínica 117(4), 129-134
Folstein, M., Folstein, S.E., McHugh, P.R. (1975). “Mini-Mental State” a Practical Method for Grading the Cognitive State of Patients for the Clinician.
Journal of Psychiatric Research, 12(3); 189-198.
Brooks R. EuroQol: the current state of play.
Health Policy. 1996; 37: 53-72.
Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R. Quality of life measurement: bibliographic study of patient assessed health outcome measures.
BMJ. 2002; 324:1417.
Rector TS, Kubo SH, Cohn JN. Patients self assessment of their congestive heart failure: II. Content, reliability and validity of a new measure. The Minnesota Living with Failure questionnaire.
Heart Failure 1987; 3:198-209.
Green CP, Porter CB, Bresnahan DR, Spertus J.A. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.
J Am Coll Cardiol.2000;1245-1255.
Styra R, Dimas M, Svitak K, Kapoor M, Osten M, Ouzounian M, et al. Toronto aortic stenosis quality of life questionnaire (TASQ): validation in TAVI patients.
BMC Cardiovasc Disord. 2020. 20(1):209.
Alarcón Alarcón T, González Montalvo JI. La Escala Socio-Familiar de Gijón, instrumento útil en el hospital general.
Rev Esp Geriatr Gerontol. 1998;33(3):175–9.
Barbanti M, Baan J, Spense MS, Iacoverlli F, Martinelli GL, Saia F, et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
BMC Cardiovasc Disord. 2017;17(1):259.
Spence MS, Baan J, Iacovelli F, Martinelli GL, Muir DF, Saia F, et al. Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation.
J Am Heart Assoc. 2020;9(15):e016990.
Barbanti M, Van Mourik MS, Spense MS, Iacovelli F, Martinelli GL, Muir DF, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre. European FAST-TAVI trial.
EuroIntervention. 2019;15(2):147-154.
Eichler S, Salzwedel A, Reib’s r, Nothroff J, Hamath A, Schikora M, et al. Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation: Predictors of functional and psychocognitive recovery.
Eur J Prev Cardiol 2017;24:257-64.
Baumbusch J, Lauck SB, Atchem L, O’Shea T, Wu S, Banner D. Understanding experiences of undergoing transcatheter aortic valve implantation: one-year follow-up.
Eur J Cardiovasc Nurs.2018;17(3):280-8.
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
N Engl J Med.2019; 380:1695-1705.
Didier R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, et al. 5- Year Clinical Outcome and Valve Durability after Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry.
Circulation. 2018;138(23):2597-2607.
Grube E, Sinning JM. The «Big Five» Complications After Transcatheter Aortic Valve Replacement: Do We Still Have to Be Afraid of Them?.
JACC Cardiovasc Interv 2019;12(4):370-372.
Nunes-Filho A, Katz M, Campos CM, Carvalho LA, Siqueira DA, Tumelero RT, et al. Impact of Acute Kidney Injury on Short- and Long-term Outcomes After Transcatheter Aortic Valve Implantation.
Rev Esp Cardiol (Engl Ed). 2019;72(1):21-29